Hansjörg Plaggemars Acquires 1,000 Shares of 4basebio (LON:4BB) Stock

4basebio PLC (LON:4BB) insider Hansjörg Plaggemars purchased 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was acquired at an average cost of GBX 585 per share, for a total transaction of £5,850.

4basebio Price Performance

4BB stock opened at GBX 584.45 on Friday. The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. The business has a 50-day simple moving average of GBX 603.43 and a two-hundred day simple moving average of GBX 736.74. The company has a market capitalization of £90.50 million, a P/E ratio of -5.90 and a beta of 1.09. 4basebio PLC has a 52-week low of GBX 520 and a 52-week high of GBX 1,220.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.